INS and Insulin resistance: Clinical research has identified a positive correlation between the elevated plasma 26RFa, the fasting insulin level, and the insulin resistance marker—Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) in diabetic and obese patients (Prévost et al., 2015, 2019b).